Vaccine‐induced immune thrombotic thrombocytopenia: Consider IVIG batch in the treatment
- 1 May 2021
- journal article
- letter
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 19 (7), 1838-1839
- https://doi.org/10.1111/jth.15361
Abstract
No abstract availableFunding Information
- Agence Nationale de la Recherche (ANR‐20‐COVI‐0093)
This publication has 12 references indexed in Scilit:
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)Journal of Thrombosis and Haemostasis, 2021
- Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccineJournal of Thrombosis and Haemostasis, 2021
- Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 PandemicThe Journal of Infectious Diseases, 2021
- No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 PandemicThe Journal of Infectious Diseases, 2020
- Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based surveyBMC Infectious Diseases, 2020
- Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?Autoimmunity Reviews, 2019
- IVIG-mediated effector functions in autoimmune and inflammatory diseasesInternational Immunology, 2017